1. Raevskaia, A. I., Shevchenko, P. P., and S. M. Karpov, “Current methods in the diagnosis and treatment of Guillain–Barré syndrome,” Vestn. Molod. Uchen., 8, No. 4, 136–141 (2019), https://www.elibrary.ru/item.asp?id=42748999, acc. Feb. 13, 2022.
2. Federal Clinical Guidelines for the Provision of Healthcare to Patients with Guillain–Barré Syndrome (online resource), https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/_kr_sgb.pdf, acc. Feb. 13, 2022.
3. Suponeva, N. A., Piradov, M. A., and Gnedovskaya, E. V., “Guillain–Barré syndrome in cities of the Russian Federation: epidemiology, diagnostic and therapeutic capabilities of reginal clinics,” Zdravookhr. Ross. Feder., 1, 19–25 (2013), https://cyberleninka.ru/article/n/sindrom-giyena-barre-v-gorodah-rossiyskoy-federatsii-epidemiologiya-diagnosticheskie-i-terapevticheskie-vozmozhnosti-regionalnyh,acc. Feb. 13, 2022.
4. Bondar’, S. A., Maslyanskii, A. L., Smirnova, A. Yu., et al., “Guillain–Barré syndrome and COVID-19: clinical cases,” Ross. Med. Zh., 5, 60–64 (2021), https://www.rmj.ru/articles/nevrologiya/Sindrom_Giyena__Barre_i_COVID-19_klinicheskie_nablyudeniya, acc. Feb. 13, 2022.
5. Chaikovskaya, A. D., Ivanova, A. D., Ternovykh, I. K., et al., “Guillain–Barré syndrome on the background of COVID-19 infection,” Sovrem. Prob. Nauki Obraz., 4, 23–28 (2020), https://doi.org/10.17513/spno.29950.